Pharmaceutical Industry

Page 99 of 100

BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

Tax inversion target companies hit by U.S. crackdown

By
September 23, 2014
Merck pays $17 billion for chemical-maker Sigma-Aldrich
Finance

Merck pays $17 billion for chemical-maker Sigma-Aldrich

By
September 22, 2014
A Walgreen Co. store in Oak Park, Ill.
Finance

Government benefits, not political pressure, convinced Walgreen to stay stateside

By
September 16, 2014
Tuesday, October 15, 2013Fortune The Most Powerful WomenWashington, D.C., USA9:00 AM SOLUTIONS DESK OPENSPhotograph by Stuart Isett/Fortune Most Powerful Women

Highest-paid female executive seeks immortality—digitally

By
September 12, 2014
How to stop Ebola
Features

How to stop Ebola

By
September 4, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
Retail

CVS stakes its claim in the healthcare market with new name change

By
September 3, 2014
Roche FY Earnings Press Conference
Finance

Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug

By
August 25, 2014
Botox
Finance

SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan

By
August 14, 2014
Kathy Giusti: Cancer Warrior
Management

Kathy Giusti: Cancer Warrior

By
August 14, 2014
Kim Le, a research associate for FivePrime Therapeutics, wor
Finance

The biotechnology boom — it’s all about better data

By
August 11, 2014
Pfizer facing growing number of lawsuits over Lipitor side effects
Finance

Pfizer facing growing number of lawsuits over Lipitor side effects

By
August 8, 2014
A Walgreen Co. store in Oak Park, Ill.
Retail

Walgreen bows to pressure, nixes inversion for Alliance Boots deal

By Laura Lorenzetti and Phil Wahba
August 6, 2014
Pfizer beats estimates as Viagra loses patent protections
Finance

Pfizer beats estimates as Viagra loses patent protections

By
July 29, 2014
Consumer Goods Inside A Tesco Metro Supermarket Store
International

Another tax ‘inversion’ deal beckons in Europe

By
July 28, 2014
Finance
Finance

Abbvie rakes in profit as investors look for assurance on Shire deal

By
July 25, 2014

Most Popular